83059-0060

Generic: bismuth subsalicylate softgel

Labeler: shield pharmaceuticals corp
NDC Directory DRUG FOR FURTHER PROCESSING DRUG FOR FURTHER PROCESSING Active

Drug Facts

Product Profile

Brand Name
Generic Name bismuth subsalicylate softgel
Labeler shield pharmaceuticals corp
Dosage Form CAPSULE, LIQUID FILLED
Active Ingredients

bismuth subsalicylate 262 mg/1

Identifiers & Regulatory

Product NDC 83059-0060
Product ID 83059-0060_4263d96a-d71f-3c17-e063-6294a90a400e
Product Type DRUG FOR FURTHER PROCESSING
Marketing Category DRUG FOR FURTHER PROCESSING
Listing Expiration 2026-12-31
Marketing Start 2024-12-11

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 830590060
Hyphenated Format 83059-0060

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Generic Name bismuth subsalicylate softgel (source: ndc)

Resolved Composition

Strengths
  • 262 mg/1
source: ndc
Packaging
  • 13500 CAPSULE, LIQUID FILLED in 1 DRUM (83059-0060-0)
source: ndc

Packages (1)

Ingredients (1)

bismuth subsalicylate (262 mg/1)

Linked Drug Pages (0)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"spl_id": "4263d96a-d71f-3c17-e063-6294a90a400e", "openfda": {}, "finished": false, "packaging": [{"description": "13500 CAPSULE, LIQUID FILLED in 1 DRUM (83059-0060-0)", "package_ndc": "83059-0060-0", "marketing_start_date": "11-DEC-24"}], "product_id": "83059-0060_4263d96a-d71f-3c17-e063-6294a90a400e", "dosage_form": "CAPSULE, LIQUID FILLED", "product_ndc": "83059-0060", "generic_name": "Bismuth Subsalicylate Softgel", "labeler_name": "Shield Pharmaceuticals Corp", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "BISMUTH SUBSALICYLATE", "strength": "262 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20241211", "listing_expiration_date": "20261231"}